U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer Pharmaceutical Investing
Pasithea Therapeutics Announces Positive PAS-004 Tablet Pharmacokinetic Data in Ongoing Phase 1/1b Trial in Adult NF1 Patients Life Science Investing
Republic Technologies Announces Definitive Investment Agreement for Up to US$100 Million Secured Convertible Note Facility Medical Device Investing
ABVC Receives US$250,000 From ForSeeCon; Vitargus Total Licensing Fee up to US$33.5 Million; US$816,000 Already Received Life Science Investing
New Data at the Asia Pacific Heart Rhythm Society 2025 Highlight the Performance of iRhythm's Zio Long-Term Continuous Monitoring in an Asian Population Life Science Investing
Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease Life Science Investing
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants Life Science Investing
NovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward Life Science Investing
